Info message
Ce contenu n'est pas disponible en français.News & Scientific Highlights
Thank You SLS
Our beamline scientists look back on 22 years of brilliant science made possible by the Swiss Light Source SLS.
Progress of the X06DA-PXIII beamline upgrade: First light in the optics hutch
On June 7, 2023, the PXIII project team successfully shone the first light into the optics hutch at the upgraded X06DA-PXIII beamline. It is an essential first step for testing new hardware and software solutions that will be implemented at SLS2.0.
SDU: Software for high throughput automated data collection at SLS MX
The Smart Digital User (SDU) software for unattended data collection has been deployed at the macromolecular crystallography beamlines at the Swiss Light Source.
Lighting up the appealing world of hybrid perovskites
Researchers from Italy, in collaboration with the Paul Scherrer Institut, successfully used the macromolecular crystallography beamline X06DA-PXIII at the Swiss Light Source to characterize promising perovkites materials used in solar cells and other photodetector devices.
Protéines maintenues à distance
Les chercheurs du PSI ont mis au point une nouvelle méthode pour fixer les protéines à la surface des particules de type viral.
How ethane-consuming archaea pick up their favorite dish
Scientists decode the structure of the enzyme responsible for the ethane fixation by – beside others – using the SLS.
Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions
In a study published in Nature Communications, researchers at the NHC Key Laboratory of Systems Biology of Pathogens in Beijing, China, in collaboration with the Paul Scherrer Institut characterize the interactions of SARS-CoV-2 orf9b and human TOM70 biochemically, and they determine the 2.2 Å crystal structure of the TOM70 cytosolic domain with a bound SARS-CoV-2 orf9b peptide.
Mode d’action du remdesivir contre le coronavirus
En coopération avec le PSI, des chercheurs de l’Université Goethe de Francfort ont probablement découvert un nouveau mécanisme d’action inconnu du remdesivir.
Combating antimicrobial resistance
In a study addressing the global health threat of drug resistance, researchers at the Biozentrum, University of Basel, have revealed how a new antibiotic, Darobactin, binds to the external membrane of gram-negative bacteria.
First MX results of the priority COVID-19 call
The Dikic group at the Goethe University in Frankfurt am Main, Germany has published the first results following the opening of the "PRIORITY COVID-19 Call” at SLS.